Invivyd (IVVD) director receives grant of 50,000 stock options at $1.04

Rhea-AI Filing Summary

Invivyd, Inc. director Kevin F. McLaughlin received a grant of stock options covering 50,000 shares of common stock. The options have an exercise price of $1.04 per share and expire on May 18, 2036. They vest in full on the earlier of May 19, 2027 or the company’s 2027 Annual Meeting of Stockholders, conditioned on his continuous service through that vesting date.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider MCLAUGHLIN KEVIN F

Role null

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (Right to Buy)	50,000	$0.00	--

Holdings After Transaction: Stock Option (Right to Buy) — 50,000 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Option grant size: 50,000 options Exercise price: $1.04 per share Expiration date: May 18, 2036 +2 more

5 metrics

Option grant size 50,000 options Stock Option (Right to Buy) granted May 19, 2026

Exercise price $1.04 per share Stock Option exercise price for Invivyd common stock

Expiration date May 18, 2036 Option term end for 50,000-share grant

Vesting date Earlier of May 19, 2027 or 2027 Annual Meeting Full vesting subject to continuous service

Holdings after grant 50,000 options Total derivative securities following transaction

Key Terms

Stock Option (Right to Buy), Grant, award, or other acquisition, Common Stock, Annual Meeting of Stockholders

4 terms

Stock Option (Right to Buy) financial

"security_title: Stock Option (Right to Buy)"

Grant, award, or other acquisition financial

"transaction_code_description: Grant, award, or other acquisition"

Common Stock financial

"underlying_security_title: Common Stock"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

Annual Meeting of Stockholders financial

"the Issuer's 2027 Annual Meeting of Stockholders"

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

MCLAUGHLIN KEVIN F

(Last) (First) (Middle)

C/O INVIVYD, INC.

209 CHURCH STREET

(Street)

NEW HAVEN CONNECTICUT 06510

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Invivyd, Inc. [ IVVD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/19/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$1.04	05/19/2026		A		50,000		(1)	05/18/2036	Common Stock	50,000	$0	50,000	D

Explanation of Responses:

1. This option was granted on May 19, 2026 and vests in full upon the earlier of (i) May 19, 2027 or (ii) the date of the Issuer's 2027 Annual Meeting of Stockholders, subject to the Reporting Person's continuous service through such vesting date.

	/s/ Jill Andersen attorney-in-fact for Kevin F. McLaughlin	05/21/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did Invivyd (IVVD) director Kevin McLaughlin report in this Form 4 filing?

Kevin F. McLaughlin reported receiving a grant of 50,000 stock options in Invivyd, Inc. The options allow him to buy common shares at $1.04 each and represent equity-based compensation rather than an open-market stock purchase or sale.

What are the key terms of Kevin McLaughlin’s Invivyd (IVVD) stock option grant?

The grant covers 50,000 shares of Invivyd common stock at a $1.04 exercise price. The options expire on May 18, 2036 and vest fully on the earlier of May 19, 2027 or the 2027 Annual Meeting, subject to continuous service.

When do Kevin McLaughlin’s Invivyd (IVVD) stock options vest?

The options vest in full on the earlier of May 19, 2027 or the date of Invivyd’s 2027 Annual Meeting of Stockholders. Vesting is contingent on Kevin McLaughlin continuing to serve the company through that vesting date.

What is the exercise price of the Invivyd (IVVD) stock options granted to Kevin McLaughlin?

The stock options have an exercise price of $1.04 per share for Invivyd common stock. This means McLaughlin can purchase up to 50,000 shares at $1.04 each once the options have vested and before they expire in 2036.

How many Invivyd (IVVD) derivative securities does Kevin McLaughlin hold after this Form 4 transaction?

After the reported transaction, Kevin McLaughlin holds 50,000 stock options as shown in the filing. These options are derivative securities tied to Invivyd common stock and reflect his position following this grant-related acquisition.